
    
      This is a prospective non interventional study. Patients enrolled in this study will receive
      Cimzia on prescription according to the instructions for use approved in Russia and within
      the frame of current standard clinical practices. The patient is evaluated at the Screening
      Visit for enrollment. A Baseline Visit is to be scheduled no more than 28 days after the
      Screening Visit. Subsequent evaluations are done routinely every 6 months.
    
  